EurekaMag.com logo
+ Site Statistics
References:
53,214,146
Abstracts:
29,074,682
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Platelet activity in acute and chronic ischemic heart disease with reference to the type of hyper lipo proteinemia



Platelet activity in acute and chronic ischemic heart disease with reference to the type of hyper lipo proteinemia



Revue Roumaine de Medecine Medecine Interne 16(4): 395-404



Platelet aggregation, serum aggregant activity and critical aggregating dose were determined in 37 patients with angina pectoris or chronic painful ischemic heart disease (CPIHD), 20 with acute myocardial infarction (AMI) and 20 control subjects. The platelet parameters are discussed in correlation with the lipoproteinemic type of the subjects. While in the patients with CPHD platelet hyperfunction was noticed particularly in cases with endogenous hypertriglyceridemia (types IIb and IV), in those with AMI this was recorded regardless of the hyperlipoproteinemia type. The mechanisms responsible for the differences are discussed.

(PDF 0-2 workdays service: $29.90)

Accession: 006133871

Download citation: RISBibTeXText

PMID: 749178



Related references

Activity of lipo protein lipase in patients with ischemic heart disease and various types of hyper lipo proteinemia after loading with lipids. Voprosy Meditsinskoi Khimii 26(6): 808-813, 1980

Comparative analysis of the frequency of main risk factors patterns of behavior and work activity of patients with ischemic heart disease and normo lipidemia or type ii and type iv hyper lipo proteinemia. Kardiologiya 19(8): 78-82, 1979

Increased in vivo and in vitro platelet function in type ii hyper lipo proteinemia and type iv hyper lipo proteinemia. Thrombosis Research 15(1-2): 95-108, 1979

Blood coagulation system indices in patients with chronic ischemic heart disease in hyper lipo proteinemia. Vrachebnoe Delo 8: 29-34, 1977

Hypo lipidemic effectiveness of diosponine in ischemic heart disease depending on the type of hyper lipo proteinemia. Kardiologiya 17(6): 136-137, 1977

Effect of physical conditioning on serum lipids in patients with type iv hyper lipo proteinemia and ischemic heart disease. Clinical Research 29(2): 248A, 1981

Effect of exercise training on serum lipids in patients with type ii hyper lipo proteinemia and ischemic heart disease. Clinical Research 28(2): 185A, 1980

Elastolytic activity and free oxy proline of the blood in different types of hyper lipo proteinemia in ischemic heart disease patients. Terapevticheskii Arkhiv: 37-40, 1977

Blood serum lipids and lipo proteins in patients with ischemic heart disease without hyper lipo proteinemia. Terapevticheskii Arkhiv 54(5): 43-46, 1982

Therapy of primary hyper lipo proteinemia type iib hyper lipo proteinemia type iii and hyper lipo proteinemia iv with biguanides as mono therapy and in combination with clofibrate. Verhandlungen der Deutschen Gesellschaft fuer Innere Medizin 79: 1294-1296, 1973

Use of miscleron in patients with ischemic heart disease and different types of hyper lipo proteinemia. Kardiologiya 16(7): 71-75, 1976

Ischemic heart disease in young adults metabolic and inst angiographic diagnosis and the prevalence of type iv hyper lipo proteinemia inst electrophoretic. Annals of Internal Medicine 69(1): 21-33, 1968

Blood viscosity in patients with ischemic heart disease and different types of hyper lipo proteinemia. Kardiologiya 17(6): 79-82, 1977

Personality characteristics of patients with ischemic heart disease with various types of hyper lipo proteinemia. Fiziologiya Cheloveka 4(5): 865-870, 1978